This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Abnormal spermatozoa
R18_ABNORMAL_SPERMATOZ
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
5464 |
4. Check minimum number of eventsNone |
5464 |
5. Include endpointsNone |
5464 |
6. Filter based on genotype QC (FinnGen only) |
4998 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R8[3-9]
- Name in latin
- Reperta abnormia in speciminibus ex organis genitalibus masculinis
Similar endpoints
↥List of similar endpoints to
Abnormal spermatozoa
based on the number of shared cases.
Similar with more cases:
- Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4998 | 10 | 4988 |
| Unadjusted period prevalence (%) | 2.28 | 0.00 | 2.29 |
| Median age at first event (years) | 68.03 | 39.30 | 68.09 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5127
- Matched controls
- 51270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
7.6
307.7
749
1127
KE1BG
NOMESCO Finland
MRI of prostate
15.5
307.7
508
361
XJH00
NOMESCO Finland
Transanal ultrasonography
4.0
307.7
1154
3459
WF002
NOMESCO Finland
Radical radiotherapy
5.6
307.7
1237
2735
XKD00
NOMESCO Finland
Uroflowmetry
5.3
307.7
3042
11011
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.4
307.7
2207
9253
XX3DW
NOMESCO Finland
Time consuming IT work
5.8
307.7
1558
3605
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
886.6
307.7
483
6
KDE20
NOMESCO Finland
Removal of foreign body from urethra
15.4
307.7
374
260
KEB00
NOMESCO Finland
Biopsy of prostate
34.3
307.7
870
304
Y77
ICPC
Malignant neoplasm prostate
5.5
307.7
855
1794
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
11.9
307.7
2487
3747
C61
ICD-10 Finland
Malignant neoplasm of prostate
13.2
307.7
3366
6484
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
11.6
307.7
3153
6202
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
22.9
307.7
327
152
L02AE02
ATC
leuprorelin; implant, parenteral
6.1
307.7
1217
2471
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
279.0
307.7
387
15
ZXC96
NOMESCO Finland
Robot assisted procedure
7.5
307.7
602
895
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
13.6
307.7
1012
913
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
32.5
307.7
710
252
116
Kela drug reimbursment
Prostate cancer
7.3
307.7
1818
3580
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
3231.0
307.7
4122
65
NK6AN
NOMESCO Finland
Total body bone isotope imaging
9.0
307.7
655
823
KE1CG
NOMESCO Finland
Extensive MRI of prostate
18.7
307.7
419
243
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
4.5
307.7
1970
6207
R86.8
ICD-10 Finland
Abnormal findings in specimens from male genital organs, other abnormal findings
117.2
307.7
181
16
ZX070
NOMESCO Finland
Intensity modified radiotherapy
8.3
297.5
407
527
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
270.0
2543
13512
L02AE04
ATC
triptorelin; parenteral
8.0
256.2
359
477
R86
ICD-10 Finland
Abnormal findings in specimens from male genital organs
84.0
232.4
123
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
223.0
629
1606
JN4AD
NOMESCO Finland
Body CT examination
2.8
193.1
1201
5018
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
19.0
190.2
150
81
N40
ICD-10 Finland
Hyperplasia of prostate
2.3
172.0
2955
19263
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.2
166.6
2648
16652
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
6.5
162.3
271
434
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
12.6
160.4
158
129
L02BX02
ATC
degarelix; parenteral
6.0
159.6
289
502
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
4.8
152.7
365
812
Z2221
NOMESCO Finland
Medical doctor
0.2
145.1
191
9068
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
7.9
137.4
190
247
R4110
NOMESCO Finland
Physiotherapy
0.3
131.7
326
10510
L02BB03
ATC
bicalutamide; oral
3.6
130.3
462
1371
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.9
118.0
218
385
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
20.6
114.4
87
43
WVA30, ,
SPAT
2.9
112.0
584
2178
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
107.2
1570
9183
YX9AW, ,
NOMESCO Finland
11.2
106.7
113
103
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
4.1
105.5
302
770
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
20.6
101.3
77
38
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
4.1
101.2
293
753
ZX080
NOMESCO Finland
Image guided radiotherapy
5.5
98.7
194
363
XX2RW, ,
NOMESCO Finland
6.1
97.4
173
294
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
18.8
96.1
76
41
UKC02
NOMESCO Finland
Cystoscopy
2.0
94.8
1486
8832
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
3.7
93.7
312
884
8148/2-C61.9
ICD-O-3
Glandular intraepithelial neoplasia, high grade of prostate gland
14.9
91.3
81
55
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.9
91.0
276
733
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
9.3
90.5
109
119
SPAT1312
SPAT
General health counselling
1.9
90.3
1634
10155
WZC30
NOMESCO Finland
Teaching
2.0
88.9
1148
6356
Z3226
NOMESCO Finland
Physiotherapist
0.2
82.2
144
5941
G04CA02
ATC
tamsulosin; oral
1.7
80.9
2692
19872
ZX050
NOMESCO Finland
Stereotactic radiotherapy
6.2
78.0
134
220
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
6.5
76.6
126
198
SPAT1263
SPAT
Sampling
1.7
70.3
2097
14832
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
15.7
68.3
59
38
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
67.5
1951
13643
SPAT1153
SPAT
Removal of sutures
1.7
66.7
1865
12915
L02BB04
ATC
enzalutamide; oral
4.1
66.0
187
472
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
0.3
63.4
218
6225
ZXA00
NOMESCO Finland
Right side
0.5
61.2
499
9815
163
Kela drug reimbursment
Abiraterone and enzalutamide
3.9
58.3
176
465
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
57.9
1454
9703
1523, ,
Kela drug reimbursment
4.9
57.5
129
271
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.8
57.2
130
276
XF400
NOMESCO Finland
ECG with 12 standard connections
0.4
57.1
250
6385
3054, ,
Kela drug reimbursment
4.8
56.7
128
270
G04BE30
ATC
drugs used in erectile dysfunction - combinations
7.1
56.3
85
122
G04BD12
ATC
mirabegron; oral
1.9
54.8
774
4347
OAB50, ,
SPAT
2.1
54.4
594
3049
L02BX03
ATC
abiraterone; oral
4.2
53.5
145
354
SPAT1262
SPAT
Handing over of treatment supplies
1.7
52.0
1170
7546
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.3
51.7
134
316
352
Kela drug reimbursment
Abiraterone and enzalutamide
4.2
51.7
138
333
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.7
50.7
1232
8102
M05BX04
ATC
denosumab; parenteral
2.6
50.7
297
1165
G04CA01
ATC
alfuzosin; oral
1.6
49.3
1391
9498
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
3.2
49.0
199
638
ZXA05
NOMESCO Finland
Left side
0.5
49.0
480
8963
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
47.7
1572
11129
SPAT1236
SPAT
Informing family of child’s disability
3.6
47.1
157
444
R86.2
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of other drugs, medicaments and biological substances
242.2
47.1
48
*
G04BE03
ATC
sildenafil; oral
3.1
47.0
200
659
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.3
46.1
380
1741
G03HA01
ATC
cyproterone; systemic
4.9
46.1
101
208
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
3.0
45.8
210
723
K62.7
ICD-10 Finland
Radiation proctitis
4.6
45.7
108
237
U04
ICPC
Incontinence urine
2.4
45.5
330
1430
EB1AA, ,
SPAT
0.1
45.4
9
1413
WX723
NOMESCO Finland
CPAP therapy
2.5
44.2
296
1237
ZX112
NOMESCO Finland
Subcutaneous
3.3
43.7
168
521
UDC00
NOMESCO Finland
Ear microscopy
2.1
43.0
444
2224
Z01.9
ICD-10 Finland
Special examination, unspecified
2.3
42.6
341
1543
A98
ICPC
Health maint/preventive medicine
2.1
42.2
4766
44155
L02BB05
ATC
apalutamide; oral
8.5
42.1
54
64
R4135
NOMESCO Finland
Rehabilitation for hearing problems
3.2
42.0
172
554
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
2.4
41.5
291
1242
Z3231
NOMESCO Finland
Registered nurse
0.6
41.3
644
10510
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
3.9
41.3
121
313
SPAT1377
SPAT
Polysomnography
2.8
41.0
205
740
SPAT1211
SPAT
Application of soft bandage
2.0
40.3
473
2481
ZXD10
NOMESCO Finland
Scheduled procedure
0.6
40.2
939
13817
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
8.0
39.2
53
67
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.8
39.0
206
766
1528, ,
Kela drug reimbursment
8.3
38.9
51
62
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
4.7
38.7
90
195
3031
Kela drug reimbursment
Apalutamidi
8.2
38.4
51
63
-1, ,
SPAT
2.8
38.4
198
727
HMAK, ,
NOMESCO Finland
1.9
38.2
485
2611
ZXC50
NOMESCO Finland
Cryotherapy
2.5
36.6
230
932
L02BX04
ATC
relugolix; oral
7.1
36.0
54
77
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.6
35.8
524
8762
Z50.0
ICD-10 Finland
Cardiac rehabilitation
3.5
35.7
124
361
SPAT1310
SPAT
Counselling related to known health issue
1.5
35.4
1486
10945
Z51.88
ICD-10 Finland
Other specified medical care
3.2
35.2
145
469
G04CB02
ATC
dutasteride; oral
1.6
35.1
872
5704
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
0.3
35.0
128
3618
WZC00, ,
SPAT
1.7
34.4
726
4551
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
2.7
33.1
182
691
TKE00
NOMESCO Finland
Needle biopsy of prostate
1.9
33.0
420
2261
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.5
32.1
208
855
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
3.1
32.1
134
437
R4110, ,
SPAT
1.7
32.0
638
3933
XX1AD
NOMESCO Finland
Other CT-examination
4.7
31.9
73
156
ZXE00
NOMESCO Finland
One hour or less
1.4
31.0
1754
13614
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
3.6
30.8
102
288
D82
ICPC
Teeth/gum disease
1.5
30.6
1469
11052
G04BE01
ATC
alprostadil; parenteral, urethral
2.4
30.5
214
913
N02BE01
ATC
paracetamol; systemic, rectal
1.6
30.2
4381
40277
J01MA12
ATC
levofloxacin; systemic
1.5
29.9
1085
7712
WZC15, ,
NOMESCO Finland
4.6
29.6
70
154
WX892
NOMESCO Finland
Monitored bed care
0.3
29.5
104
3004
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
7.9
29.4
40
51
KE1CG, ,
SPAT
10.1
29.1
33
33
N39.3
ICD-10 Finland
Stress incontinence
3.3
28.6
106
322
WX290
NOMESCO Finland
Other blockage of nerve
1.4
27.9
1880
14979
R4120
NOMESCO Finland
Occupational therapy
0.2
27.3
35
1831
R31
ICD-10 Finland
Unspecified haematuria
1.5
26.5
829
5691
SPAT1053
SPAT
Memory test
1.5
26.1
863
5995
WX780
NOMESCO Finland
Remote monitoring CPAP
2.1
26.1
267
1330
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
1.7
26.0
491
2974
KC1GB
NOMESCO Finland
Cystography with X-ray
3.0
25.8
117
401
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
25.5
3224
28281
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
24.6
717
4838
SPAT1301
SPAT
No procedures
1.4
24.3
1476
11491
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.0
24.1
259
1312
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.3
24.1
188
841
HAHOM, ,
NOMESCO Finland
4.6
23.5
56
124
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.4
23.3
160
677
ZXD20
NOMESCO Finland
Day surgery
0.4
23.1
152
3351
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
3.5
23.1
79
228
R86.7
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal histological findings
+∞
22.9
22
*
N41.9
ICD-10 Finland
Inflammatory disease of prostate, unspecified
2.5
22.9
150
621
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
2.9
22.3
107
379
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
27.4
22.2
30
11
G04CB01
ATC
finasteride; oral
1.4
22.2
1122
8439
Z01.2
ICD-10 Finland
Dental examination
1.4
22.1
1786
14508
WX320
NOMESCO Finland
Spinalanesthesy
1.4
22.0
1225
9369
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
4.4
21.7
54
124
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.8
21.3
346
2005
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
5.6
21.3
40
72
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
5.2
21.2
43
83
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
0.6
21.1
597
8646
Z51.0
ICD-10 Finland
Radiotherapy session
3.1
20.9
89
295
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
7.1
20.8
31
44
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
20.5
657
4514
A28
ICPC
Limited function/disability NOS
0.6
20.4
462
7033
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1.9
20.3
253
1350
SPAT1131
SPAT
Colonoscopy
2.2
20.2
165
753
J01MA02
ATC
ciprofloxacin; systemic
1.3
20.1
2069
17348
WX110, ,
SPAT
0.1
20.1
12
1103
Z26.9
ICD-10 Finland
Need for immunization against unspecified infectious disease
3.0
19.9
89
303
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
3.4
19.9
71
211
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
1.6
19.7
561
3755
WX402
NOMESCO Finland
General anaesthesia
1.4
19.6
1017
7662
WF090
NOMESCO Finland
Profylactic radiotherapy
3.2
19.5
77
244
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
21.6
19.5
28
13
N41.0
ICD-10 Finland
Acute prostatitis
2.0
19.4
201
1006
ZX112, ,
SPAT
4.6
19.3
45
98
H25.8
ICD-10 Finland
Other senile cataract
1.5
19.2
580
3934
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.6
19.2
525
3483
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
4.7
19.1
44
95
WX704
NOMESCO Finland
Intubation
0.4
19.1
115
2628
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
18.9
1543
12484
SPAT1260
SPAT
Consultation of another employee
1.4
18.7
787
5705
EB4VA, ,
NOMESCO Finland
1.5
18.6
542
3647
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
5.7
18.5
34
60
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
0.3
18.4
38
1466
Z01.3
ICD-10 Finland
Examination of blood pressure
3.1
18.4
77
253
KH1AD
NOMESCO Finland
CT of urinary organs
1.9
18.1
239
1301
N30.4
ICD-10 Finland
Irradiation cystitis
5.7
18.0
33
58
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
0.1
17.9
*
570
EBA00, ,
SPAT
0.1
17.6
*
533
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
36.8
17.6
22
6
TPH04
NOMESCO Finland
Cathetrisation of vein
0.7
17.5
656
9034
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
4.1
17.5
47
115
XKC03
NOMESCO Finland
Water cystometry
2.3
17.4
128
559
C05AA08
ATC
fluocortolone; rectal, topical
1.5
17.4
602
4196
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.8
17.3
256
1443
SPAT1043
SPAT
Audiometry
1.5
17.1
538
3678
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
16.8
696
5024
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
2.3
16.7
124
544
WX002
NOMESCO Finland
Sedation and analgesia
0.7
16.7
471
6858
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
16.6
704
5104
B01AB10
ATC
tinzaparin; parenteral
1.5
16.5
506
3436
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
0.3
16.5
49
1546
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.6
16.4
291
4711
XX2VW
NOMESCO Finland
Radiologic consultation
5.7
16.3
30
53
WX290, ,
SPAT
0.1
16.2
*
526
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.5
16.2
100
404
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
2.7
16.1
84
312
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
0.2
16.0
27
1179
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
3.7
15.9
50
137
H25.0
ICD-10 Finland
Senile incipient cataract
1.6
15.8
346
2176
M01AH05
ATC
etoricoxib; oral
1.3
15.7
2591
22828
WX872
NOMESCO Finland
Intensive care
0.4
15.6
107
2323
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
0.2
15.5
17
984
TDA90, ,
SPAT
1.6
15.4
405
2660
-51
ICPC
I&d/flush/aspiration
2.9
15.1
71
250
EB1SA, ,
SPAT
0.1
15.0
10
842
WF099
NOMESCO Finland
Other radiotherapy
3.7
14.8
46
125
-44
ICPC
Preventive immunization/medic
1.6
14.8
382
2498
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.3
14.6
53
160
R86.6
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal cytological findings
+∞
14.6
14
*
Z2446
NOMESCO Finland
Social worker
0.3
14.5
51
1475
WZC30, ,
SPAT
1.6
14.4
396
2625
-54
ICPC
Repair/fix-suture/cast/prosth device
2.3
14.4
106
464
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
4.2
14.4
38
92
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.3
14.2
1052
8336
SCA02
NOMESCO Finland
Preventive oral health care
1.6
14.1
311
1957
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
14.0
726
5440
KDW96
NOMESCO Finland
Other operations on urethra
4.8
14.0
31
65
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
13.9
1290
10540
XA800
NOMESCO Finland
Neuropsychological investigation
0.3
13.8
34
1186
KED22
NOMESCO Finland
Transurethral resection of prostate
1.5
13.8
535
3805
130
Kela drug reimbursment
Malignant tumour
0.6
13.8
268
4254
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
13.7
535
3811
GD1LA
NOMESCO Finland
GD
0.1
13.7
6
509
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
0.4
13.7
80
1848
N41.1
ICD-10 Finland
Chronic prostatitis
1.8
13.7
217
1251
ZXD00
NOMESCO Finland
Emergency procedure
1.9
13.6
164
867
WX199
NOMESCO Finland
Other local analgesia
1.8
13.5
192
1071
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
0.1
13.2
6
498
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.0
13.1
137
690
L03AA14
ATC
lipegfilgrastim; parenteral
2.8
13.1
63
225
SPAT1304
SPAT
Counselling and guidance related to ageing
1.5
13.0
361
2400
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
0.4
13.0
50
1384
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
12.9
1138
9219
WW200, ,
SPAT
1.3
12.9
1375
11414
WPB10
NOMESCO Finland
Making a convalescent care decision
3.7
12.9
40
109
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.6
12.9
271
1687
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.5
12.6
76
304
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
12.6
622
4617
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
1.9
12.6
165
898
EB1VA, ,
NOMESCO Finland
1.4
12.6
697
5276
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.1
12.4
122
602
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.0
12.4
127
636
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.5
12.3
73
290
H81
ICPC
Excessive ear wax
1.3
12.3
969
7727
TPH07
NOMESCO Finland
Cathetrisation of artery
0.7
12.1
340
4979
WPA11
NOMESCO Finland
Developing a plan for palliative care
4.8
12.1
27
57
JGA28
NOMESCO Finland
Endoscopic contact coagulation in rectum
5.5
12.1
23
42
R01AD12
ATC
fluticasone furoate; nasal
1.3
12.0
934
7430
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.5
11.8
135
2471
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
0.5
11.8
116
2225
WX720
NOMESCO Finland
Own respiration
0.4
11.8
69
1594
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
0.4
11.8
44
1236
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
0.4
11.8
47
1278
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
11.8
394
2724
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
11.6
538
3949
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.0
11.6
131
679
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
2.1
11.6
108
522
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
3.6
11.6
37
103
A23
ICPC
Risk factor NOS
0.5
11.6
108
2106
R83
ICPC
Respiratory infection other
0.7
11.6
341
4947
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
11.5
1064
8660
B01AC04
ATC
clopidogrel; oral
0.7
11.4
701
8981
FP1E5, ,
SPAT
4.7
11.4
26
56
L03AA13
ATC
pegfilgrastim; parenteral
1.9
11.3
144
777
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
2.1
11.3
100
474
D19
ICPC
Teeth/gum symptom/complaint
0.7
11.3
681
8748
SPAT1336
SPAT
Request for examination
0.2
11.2
18
804
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
11.2
999
8088
ZYD01, ,
SPAT
2.9
11.1
52
183
R33
ICD-10 Finland
Retention of urine
1.4
11.1
612
4623
SPAT1281
SPAT
Other administrative function
1.5
11.1
320
2145
L02AE03
ATC
goserelin; implant
2.5
11.0
65
258
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
11.0
359
2470
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
13.9
10.9
18
13
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
0.6
10.9
217
3424
SPAT1325
SPAT
Vaccination
1.2
10.8
1513
12919
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
10.8
649
8346
EBA05, ,
SPAT
0.1
10.7
*
330
Z50.1
ICD-10 Finland
Other physical therapy
1.6
10.7
219
1354
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.7
10.7
206
1254
OAA53, ,
SPAT
5.6
10.7
20
36
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
10.7
686
5304
WX725
NOMESCO Finland
Noninvasive ventilation
0.5
10.6
87
1769
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
0.2
10.6
13
691
M01AE02
ATC
naproxen; oral, rectal
1.2
10.4
2180
19386
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
2.7
10.4
53
196
ZXD35
NOMESCO Finland
Usual procedure
0.3
10.3
22
828
JN5AN
NOMESCO Finland
Total body isotope imaging
16.1
10.3
16
10
SPAT1395
SPAT
Health check-up of persons outside student and working life
2.1
10.3
90
425
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.8
10.3
946
11513
R4190
NOMESCO Finland
Nutritional therapy
0.3
10.3
31
965
J01DB01
ATC
cefalexin; oral
1.2
10.3
3831
36062
SPAT1016
SPAT
Examination of vision
1.6
10.3
219
1370
L02BB06
ATC
darolutamide; oral
4.9
10.2
22
45
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
10.2
2548
23028
WX204
NOMESCO Finland
Axillary plexus blockaced
1.8
10.2
146
819
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
2.0
10.1
110
563
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
0.3
10.1
32
972
SPAT1161
SPAT
Ultrasound examination of urinary bladder
3.3
10.1
36
108
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
0.6
10.1
237
3605
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.1
10.1
92
442
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
10.1
2904
26598
Z00.8
ICD-10 Finland
Other general examinations
1.5
10.1
312
2124
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
3.0
10.1
42
139
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
10.0
1069
12786
E29.1
ICD-10 Finland
Testicular hypofunction
2.1
10.0
89
424
J05AB01
ATC
aciclovir; systemic
1.3
9.9
712
5589
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
9.9
171
1011
SGA01
NOMESCO Finland
Emergency treatment
1.4
9.8
555
4207
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
0.4
9.8
37
1030
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
0.2
9.7
11
617
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
9.7
844
10348
KBV10
NOMESCO Finland
Removal of stent from ureter
2.6
9.6
53
204
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
0.2
9.6
16
696
A97
ICPC
No disease
0.7
9.6
518
6777
S18
ICPC
Laceration/cut
1.2
9.5
2333
20995
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
2.6
9.5
55
217
JN4BD
NOMESCO Finland
Extensive body CT
1.4
9.5
536
4063
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
9.5
1522
13146
T45
ICPC
Metabolic, Observ/health educat/advice/diet
0.1
9.4
5
372
SFA20
NOMESCO Finland
Two-surface restoration
1.2
9.3
2304
20737
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
9.3
1547
13406
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.5
9.2
250
1655
SFA10
NOMESCO Finland
One-surface restoration
1.2
9.2
2176
19502
ZXC15
NOMESCO Finland
Use of photodynamic technique
2.1
9.1
85
413
WX220
NOMESCO Finland
Ilioinguinal plexus blockade
3.3
9.0
33
101
YHMAS, ,
NOMESCO Finland
3.3
9.0
33
101
XX1VW
NOMESCO Finland
Written report from radiologist
2.8
9.0
43
154
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
0.7
9.0
315
4427
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
0.4
9.0
37
987
SGC00
NOMESCO Finland
Medication, disinfection of root canals
1.4
9.0
364
2611
WPA44
NOMESCO Finland
Nursing home for palliative care
4.1
9.0
24
59
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.5
8.9
251
1674
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
0.4
8.9
43
1072
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
8.9
1703
14942
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.7
8.8
158
946
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
0.4
8.8
46
1107
N42.8
ICD-10 Finland
Other specified disorders of prostate
2.9
8.8
39
134
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.2
8.8
1068
8945
R50.9
ICD-10 Finland
Fever, unspecified
1.3
8.8
685
5437
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
3.4
8.8
30
88
UJF32
NOMESCO Finland
Coloscopy
1.2
8.7
1226
10428
KBV00
NOMESCO Finland
Insertion of stent into ureter
2.8
8.7
41
146
Z71.9
ICD-10 Finland
Counselling, unspecified
1.5
8.7
290
2006
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
0.2
8.7
11
569
XA421, ,
SPAT
2.7
8.6
45
169
EAV, ,
NOMESCO Finland
0.1
8.6
*
302
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.8
8.6
128
728
A62
ICPC
General and Unspecified, Administrative procedure
0.2
8.6
13
598
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
1.6
8.6
173
1069
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
8.5
359
2592
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
8.5
635
5009
R4130
NOMESCO Finland
Speech therapy
0.3
8.4
23
750
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
8.3
1357
11707
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
+∞
8.3
8
*
SPAT1342
SPAT
Referral to specialised care
0.0
8.3
*
236
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
8.2
634
5024
XCH00
NOMESCO Finland
Eye pressure measurement
1.5
8.2
221
1463
ZXH09, ,
SPAT
0.2
8.2
6
357
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.7
8.1
224
3296
Z71.8
ICD-10 Finland
Other specified counselling
0.8
8.1
893
10689
ZYY01
NOMESCO Finland
Contact between professionals
4.5
8.1
19
42
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
0.1
8.1
*
289
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.4
8.1
378
2781
RD210, ,
NOMESCO Finland
0.2
8.0
5
331
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.6
8.0
167
1041
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
0.5
8.0
54
1174
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
22.0
8.0
11
5
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
2.3
8.0
57
249
SPAT1291
SPAT
Other function in accordance with NCSP classification
2.2
7.9
61
275
WW502
NOMESCO Finland
Autotransfusion
0.0
7.9
*
229
XX9TE
NOMESCO Finland
Compementary ultrasound examination
3.0
7.9
34
115
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.9
2326
21148
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
1.9
7.9
92
485
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
0.5
7.9
52
1139
WX000, ,
SPAT
4.6
7.9
18
39
S02.5
ICD-10 Finland
Fracture of tooth
1.9
7.9
97
521
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.7
7.8
128
749
B01AF01
ATC
rivaroxaban; oral
1.3
7.8
648
5182
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.6
7.8
164
1026
A04
ICPC
Weakness/tiredness general
0.7
7.8
321
4386
RS222, ,
NOMESCO Finland
0.0
7.7
*
225
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
7.7
317
2283
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
2.7
7.7
39
145
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
3.3
7.6
28
86
Z2445
NOMESCO Finland
Psychologist
0.3
7.6
20
662
SPAT1366
SPAT
Health check-up performed based on health survey in students of universities, universities of applied sciences etc.
3.6
7.6
24
67
OAB44, ,
SPAT
1.4
7.5
320
2316
XCK10
NOMESCO Finland
Photography of fundus of eye
0.7
7.5
245
3488
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
7.5
1156
13381
A10BB01
ATC
glibenclamide; oral
0.5
7.4
72
1376
SPAT1125
SPAT
Stoma care and guidance
1.9
7.4
82
426
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
0.2
7.3
13
540
A04AA02
ATC
granisetron; systemic, transdermal
1.5
7.3
259
1813
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.4
7.3
346
2550
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
7.3
733
6001
H02AB06
ATC
prednisolone; systemic
1.2
7.3
2094
18961
K05
ICD-10 Finland
Gingivitis and periodontal diseases
2.3
7.2
51
222
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
7.2
2215
20154
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
2.6
7.2
39
150
K04.0
ICD-10 Finland
Pulpitis
1.4
7.2
262
1846
ZX137
NOMESCO Finland
To penis
30.0
7.1
9
*
ULA02
NOMESCO Finland
Kolposcopy
30.0
7.1
9
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.2
7.1
980
8296
-, ,
ICD-10 Finland
0.2
7.1
12
513
S21
ICPC
Skin texture symptom/complaint
0.7
7.1
403
5243
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
7.1
1352
11815
A91
ICPC
Abnormal result investigation NOS
0.5
7.0
81
1472
KE1DG, ,
SPAT
8.8
7.0
14
16
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
3.6
7.0
22
61
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
3.6
7.0
22
61
H02AB07
ATC
prednisone; oral
0.7
7.0
286
3914
SPAT1097
SPAT
Recording of ECG
1.3
7.0
667
5425
ZX120
NOMESCO Finland
Intravenous
0.7
7.0
202
2940
A01
ICPC
Pain general/multiple sites
0.7
6.9
170
2560
A55
ICPC
General and Unspecified, Local injection/infiltration
2.2
6.9
55
252
A29
ICPC
General symptom/complaint other
0.7
6.9
344
4564
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
0.0
6.9
*
202
UJF30
NOMESCO Finland
Ileoscopy through colon
1.3
6.9
419
3213
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
3.6
6.9
22
62
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
2.0
6.9
72
367
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
0.4
6.8
30
773
C61, D400,
ICD-10 Finland
10.9
6.8
12
11
L17
ICPC
Foot/toe symptom/complaint
0.8
6.8
909
10680
WPA13
NOMESCO Finland
Palliative consultation
2.9
6.7
30
104
G04BD08
ATC
solifenacin; oral
1.4
6.7
271
1947
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.2
6.6
1109
9564
R44
ICPC
Respiratory, Preventive immunization/medic
0.2
6.6
8
349
SPAT1079
SPAT
Echocardiography
2.0
6.6
64
317
A10BA02
ATC
metformin; oral
0.8
6.6
1216
13875
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
0.2
6.6
10
454
K22
ICPC
Risk factor cardiovascular disease
0.6
6.5
132
2071
ZXF10
NOMESCO Finland
Interruption caused by technical failure of equipment
3.8
6.5
19
50
M79.6
ICD-10 Finland
Pain in limb
1.2
6.5
1622
14479
L57.0
ICD-10 Finland
Actinic keratosis
1.3
6.5
522
4155
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
1.7
6.5
117
705
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
6.5
1155
13225
AS4
HP
Physiological pacemaker insertion DDD (R)
1.9
6.5
71
368
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.4
6.4
284
2071
ZX100
NOMESCO Finland
Oral
2.0
6.4
68
348
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.3
6.4
498
3948
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
0.4
6.4
25
678
XCD10
NOMESCO Finland
Electrophysiological examination of eye
0.3
6.4
16
542
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.4
6.4
258
1853
KED76
NOMESCO Finland
TUVP
2.1
6.4
55
261
A10AC01
ATC
insulin (human); parenteral
0.7
6.4
167
2477
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
3.6
6.3
20
56
-39
ICPC
Physical function test
3.5
6.3
21
61
TQB05
NOMESCO Finland
Puncture of skin of trunk
3.2
6.3
23
71
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
2.7
6.3
31
114
-60
ICPC
Result test/procedure
0.6
6.3
87
1497
NK4EA, ,
SPAT
3.8
6.3
18
47
R86.3
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of substances chiefly nonmedicinal as to source
+∞
6.2
6
*
S02.51
ICD-10 Finland
Fracture of tooth, open
1.4
6.2
324
2427
D07BC01
ATC
betamethasone and antiseptics; topical
0.7
6.2
293
3921
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.4
6.2
233
1652
ZXE30
NOMESCO Finland
More than five and less than seven hours
0.6
6.2
99
1641
R03AC03
ATC
terbutaline; inhalant
0.7
6.1
223
3112
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
1.5
6.1
184
1251
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
1.8
6.1
88
499
T93
ICPC
Lipid disorder
0.7
6.1
151
2264
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
0.5
6.1
71
1281
U13
ICPC
Bladder symptom/complaint other
1.7
6.1
94
544
A02BC03
ATC
lansoprazole; oral
0.8
6.1
842
9874
TQW40, ,
SPAT
1.3
6.0
433
3397
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.6
6.0
120
743
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
3590
21656
3.19
317.38
6.0
3.3
0.95
0.78
ug/l
21.99
3253
15074
1247
3741
4.08
307.65
4.5
4.7
1.21
1.22
mmol/l
0.20
1045
3304
1535
5269
3.73
307.65
4.1
3.8
—
—
—
0
0
2650
11801
3.58
307.65
3.9
3.4
0.01
0.12
estimate
0.91
1363
3699
4787
36836
5.52
243.84
12.0
5.8
8.25
3.32
ug/l
6.94
4488
33298
4172
29626
3.19
235.92
7.2
4.8
15.81
22.58
%
316.40
3658
15330
2456
13662
2.53
225.41
3.7
4.0
0.00
0.00
estimate
0.90
1496
4179
2878
17559
2.46
211.20
4.0
3.9
0.07
0.04
estimate
0.17
1491
4017
1600
7528
2.64
205.04
2.4
2.3
11.03
13.40
nmol/l
19.04
1447
6696
1073
4389
2.83
178.24
3.9
4.4
0.74
0.74
%
0.02
288
1574
2421
34325
0.44
174.88
16.7
26.8
334.46
333.61
g/l
2.62
2400
34149
3909
29599
2.35
145.18
4.4
4.7
122.84
631.95
e6/l
1.20
50
517
449
1226
3.92
143.37
2.7
2.8
16.46
16.32
%
0.34
437
1196
422
1175
3.82
130.77
4.0
4.9
2.20
2.50
mmol/l
1.24
273
776
3288
23724
2.08
130.67
4.0
3.8
0.00
0.00
estimate
1.08
1675
4848
422
1176
3.82
130.60
4.0
4.9
4.92
4.97
kpa
0.50
412
1144
422
1181
3.80
129.79
4.0
4.9
8.38
8.53
kpa
1.00
412
1148
1806
10531
2.10
129.01
3.6
3.2
547.89
573.69
mosm/kgh2o
5.83
1644
9288
3315
24112
2.06
127.23
4.0
3.8
0.20
0.32
estimate
0.16
1581
4444
2898
20129
2.01
126.18
20.4
13.1
0.00
0.00
e9/l
0.04
2779
16300
3287
24029
2.03
121.82
4.0
3.8
0.00
4.75
estimate
4.33
1699
4901
2022
12543
2.01
119.76
3.1
2.9
2.87
2.70
e6/l
0.32
1871
11468
453
11457
0.34
112.18
3.3
3.6
0.00
0.24
2.81
22
113
4778
41258
3.32
110.48
22.5
20.4
74.56
75.74
ml/min/173m2
4.61
4687
38695
322
884
3.82
101.36
1.9
2.0
1.80
1.75
mmol/l
0.24
311
857
650
13162
0.42
93.67
3.0
4.9
84.14
81.18
%
2.39
631
12945
1649
10306
1.88
89.39
2.0
1.8
427.45
27589420.20
pmol/l
6.72
1192
8594
394
1349
3.08
87.33
3.0
3.2
89.27
89.00
%
0.30
382
1310
2753
20253
1.78
85.69
4.8
4.4
138.93
77.07
ng/l
0.30
2384
16338
416
1530
2.87
80.99
3.1
3.2
7.97
7.87
kpa
0.56
404
1491
4223
35722
2.03
80.17
9.5
9.4
81.71
81.56
u/l
0.06
4036
34052
935
4985
2.07
79.26
2.7
2.7
0.22
0.44
e6/l
5.10
925
4840
290
7870
0.33
78.05
4.8
8.6
1.35
0.77
mmol/l
2.36
225
6455
573
2524
2.43
77.36
3.9
3.4
1.02
1.02
ratio
0.33
564
2310
300
7951
0.34
76.77
4.7
8.7
5.04
5.06
kpa
0.19
285
7663
300
7949
0.34
76.72
4.7
8.7
10.84
11.94
kpa
4.45
285
7655
225
6652
0.31
70.86
5.2
9.6
120.55
122.39
g/l
0.64
214
6501
110
4742
0.22
66.09
2.3
2.7
58.47
55.60
u/l
0.04
92
4054
292
7258
0.37
63.66
4.7
8.9
93.60
95.30
%
2.78
276
7003
2124
15353
1.65
63.61
3.3
3.8
0.37
0.45
e6/l
0.98
1913
11590
2395
17856
1.64
63.35
3.5
3.9
242.29
96.62
e6/l
2.15
2161
14032
87
4090
0.20
59.33
8.0
11.2
15.71
16.12
%
0.64
87
3953
2490
19027
1.60
57.48
3.7
4.4
162.68
95.22
e6/l
1.36
2255
14348
4893
45182
2.82
55.48
27.9
27.6
92.27
91.31
umol/l
0.91
4848
44697
3230
26408
1.60
54.80
18.6
20.0
1.29
1.36
inr
11.05
2945
22362
4830
44396
2.52
54.02
22.2
25.5
139.62
139.63
mmol/l
0.08
4685
43651
4834
44474
2.52
53.51
22.5
25.8
4.04
4.04
mmol/l
0.22
4685
43683
4903
45421
2.82
53.32
30.0
30.8
228.56
228.61
e9/l
0.02
4831
44397
4903
45425
2.82
53.24
30.1
31.6
40.42
40.93
%
3.39
4830
44864
4903
45427
2.82
53.19
29.9
30.7
91.89
91.92
fl
0.18
4832
44887
4903
45428
2.81
53.17
30.0
30.8
4.48
4.52
e12/l
4.28
4823
44220
4903
45430
2.81
53.13
30.1
30.8
6.89
7.03
e9/l
3.78
4825
44216
4903
45432
2.81
53.09
30.3
31.0
136.89
137.49
g/l
1.77
4830
44899
615
10808
0.51
52.89
4.1
4.5
294.25
650.58
ng/l
1.75
454
9560
4481
40112
1.93
52.52
5.0
4.8
1.32
1.31
mmol/l
0.07
3736
36699
488
2357
2.18
52.23
2.9
3.1
24.60
24.51
mmol/l
0.18
478
2316
311
1232
2.62
52.02
3.5
3.8
7.19
7.77
mmol/l
3.50
301
1197
346
1472
2.45
49.78
3.4
3.6
1.63
1.66
mmol/l
0.19
336
1428
4599
41680
2.00
49.73
6.0
5.6
1.31
1.30
mmol/l
1.69
3871
38502
745
4298
1.86
48.08
3.4
3.9
5.06
5.10
kpa
0.72
713
4102
489
2447
2.10
47.62
2.3
2.2
0.01
0.42
estimate
0.56
121
666
4609
41957
1.97
46.84
6.0
5.7
4.34
4.21
mmol/l
13.27
3900
39076
249
5845
0.40
46.08
4.5
8.9
1.42
1.39
mmol/l
0.17
242
5732
4639
42400
1.99
45.42
18.9
20.7
24.93
30.26
mg/l
21.80
4006
36287
4813
44616
2.29
45.02
13.5
13.7
26.72
28.37
u/l
7.14
4544
43279
134
4172
0.30
44.87
6.3
10.7
24.30
24.11
mmol/l
0.35
134
4085
502
8974
0.51
44.19
4.6
8.4
104.67
104.54
mmol/l
0.24
502
8969
158
479
3.37
42.62
1.4
1.6
—
—
—
0
0
4556
41682
1.84
40.33
5.9
5.9
6.15
6.22
mmol/l
2.98
3765
38096
315
1412
2.31
40.16
2.6
2.4
131.15
130.04
g/l
0.31
294
1064
680
10777
0.57
38.74
2.9
4.1
1.02
1.02
kg/l
0.91
571
7368
4634
42750
1.87
38.06
6.3
6.5
2.55
2.43
mmol/l
14.16
3904
39633
902
5936
1.63
35.45
5.2
5.4
30.81
31.93
%
2.03
532
4022
133
417
3.25
34.03
1.4
1.5
—
—
—
0
0
1977
15505
1.45
33.85
2.9
3.9
2.33
2.34
mmol/l
0.18
1828
14033
390
7007
0.52
33.69
1.6
2.0
—
—
—
0
0
174
4201
0.39
33.63
4.0
7.8
24.26
24.32
mmol/l
0.07
161
4027
123
373
3.35
33.21
1.4
1.5
—
—
—
0
0
605
3653
1.74
32.73
3.0
3.7
1.84
1.68
mmol/l
0.60
428
2626
3253
28111
1.43
31.56
3.6
3.6
61.89
62.32
u/l
0.07
2844
26233
4489
41441
1.67
31.38
7.5
7.7
40.64
40.78
mmol/mol
0.35
3862
38581
193
777
2.54
31.16
4.5
4.7
10.43
11.15
pmol/l
0.36
193
777
3431
29979
1.44
31.01
4.6
6.2
6.88
7.00
mmol/l
1.50
3320
28830
117
365
3.26
30.21
1.4
1.5
—
—
—
0
0
715
4664
1.62
28.61
2.2
2.1
0.03
0.01
estimate
0.73
196
900
376
2054
1.90
28.15
1.8
1.9
—
—
—
0
0
14
1468
0.09
27.46
2.0
3.8
2.44
1.96
index
—
9
817
3009
25988
1.38
27.01
6.6
7.7
11.50
13.45
umol/l
19.36
2830
24988
1953
15726
1.39
26.95
2.6
2.9
60.67
76.52
u/l
1.28
1760
14697
394
2233
1.83
26.23
1.9
2.1
—
—
—
0
0
225
1057
2.18
25.57
1.6
1.8
—
—
—
0
0
133
499
2.71
24.80
2.4
2.2
663.69
681.93
ml
0.22
89
316
177
770
2.35
24.18
1.5
1.6
—
—
—
0
0
352
5961
0.56
24.09
2.6
3.1
9.25
10.75
umol/l
0.69
280
5415
3629
32617
1.39
23.66
4.6
4.4
12.78
12.98
mm/h
0.29
3169
30385
4118
37928
1.44
22.49
4.4
4.4
2.06
2.04
mu/l
0.27
3437
34381
497
7543
0.62
21.86
1.6
1.9
—
—
—
0
0
717
9956
0.67
20.48
3.0
3.5
0.79
0.89
e6/l
0.84
613
5643
3302
29530
1.33
20.30
3.5
3.4
15.08
14.96
pmol/l
1.69
2728
26596
22
1257
0.17
19.55
1.3
1.3
—
—
—
0
0
16
1136
0.14
19.19
1.2
1.3
—
—
—
0
0
16
1136
0.14
19.19
1.2
1.3
—
—
—
0
0
294
1689
1.79
18.66
3.1
2.8
1.78
1.76
mg/l
0.12
258
1521
195
985
2.02
18.36
1.3
1.4
—
—
—
0
0
77
257
3.03
17.89
1.4
1.5
1.86
3.52
%
0.94
14
62
402
6087
0.63
17.11
4.3
8.2
—
—
—
0
0
98
383
2.59
16.97
1.7
1.8
2.14
1.07
u/field
1.16
63
214
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
117
2531
0.45
16.84
2.3
3.0
0.39
0.33
iu/ml
0.98
76
1386
117
502
2.36
16.60
1.5
1.5
30.21
24.57
%
0.71
56
324
95
2189
0.42
16.10
2.6
4.5
1.73
1.45
mmol/l
0.86
88
2147
159
792
2.04
15.60
1.5
1.6
—
—
—
0
0
1721
14432
1.29
15.50
3.1
3.7
10.56
457.48
estimate
0.54
26
65
709
9436
0.71
15.31
1.8
2.2
31.46
30.13
s
5.33
693
9203
294
1796
1.68
14.99
1.9
1.8
—
—
—
0
0
228
3840
0.57
14.91
1.4
1.5
—
—
—
0
0
85
1967
0.42
14.57
1.6
2.6
0.00
0.04
g/l
4.08
51
1775
135
650
2.11
14.53
1.5
1.5
63.21
63.74
%
0.05
66
423
142
709
2.03
13.89
1.8
17.1
7.33
7.43
mmol/l
0.18
132
592
83
1901
0.43
13.87
2.0
2.6
0.00
0.00
g/l
0.50
42
1671
423
2877
1.51
13.68
1.8
2.0
2.03
2.22
ug/l
0.07
377
2573
203
1169
1.77
12.85
1.3
1.4
—
—
—
0
0
203
1171
1.76
12.77
1.3
1.5
—
—
—
0
0
335
4966
0.65
12.70
3.4
3.2
227.81
232.65
ng/l
0.03
318
4580
221
1311
1.72
12.60
3.6
3.7
3598.08
1357.56
u/ml
0.30
197
1212
714
9204
0.74
12.22
3.1
3.7
0.62
0.66
e6/l
0.19
605
4864
236
3711
0.62
11.66
1.6
1.8
—
—
—
0
0
2508
22463
1.23
11.59
6.0
6.9
24.65
25.30
%
2.21
2331
21254
2092
18417
1.23
11.32
2.2
2.0
1.35
1.34
mmol/l
0.03
1193
15284
2515
22608
1.22
10.97
2.9
3.1
—
—
estimate
—
0
0
122
2228
0.54
10.62
2.1
3.9
454.83
2706.82
u/ml
1.10
99
1967
179
1052
1.73
10.61
3.8
3.8
1.62
1.63
%
0.01
160
934
243
1547
1.60
10.58
1.5
1.7
—
—
—
0
0
35
1027
0.34
10.32
1.3
1.2
—
—
—
0
0
61
244
2.52
10.23
2.0
1.7
1.57
2.55
u/field
0.78
51
172
2139
19028
1.21
10.04
3.1
3.2
246.26
200.11
ug/l
4.59
1819
17611
23
50
4.62
9.99
3.1
2.1
0.09
0.18
u/field
0.48
23
50
36
1019
0.35
9.87
1.3
1.2
—
—
—
0
0
133
2310
0.56
9.74
1.9
2.6
9.57
10.34
g/l
1.49
109
2075
66
282
2.36
9.62
1.5
2.4
—
—
—
0
0
66
282
2.36
9.62
1.5
2.4
—
—
—
0
0
66
282
2.36
9.62
1.5
2.4
—
—
—
0
0
66
282
2.36
9.62
1.5
2.4
—
—
—
0
0
2037
18104
1.21
9.48
3.3
3.5
1695.50
1711.32
ng/l
0.04
1690
16022
2047
22799
0.83
9.34
5.6
8.1
1.21
1.20
mmol/l
24.44
1765
21222
79
372
2.14
9.16
1.2
1.2
2.24
2.17
mmol/l
0.12
73
352
14
636
0.22
9.03
1.7
2.6
1032.04
1137.09
mg
0.10
14
630
73
337
2.18
8.90
3.6
3.6
—
—
—
0
0
417
5571
0.73
8.79
2.3
2.5
6.15
8.76
ug/l
1.28
371
5003
59
1282
0.45
8.70
1.4
1.3
—
—
—
0
0
210
1357
1.57
8.64
1.3
1.5
—
—
—
0
0
394
2917
1.38
8.08
4.0
4.0
25.19
24.92
mmol/l
0.92
387
2821
55
238
2.33
7.86
1.2
1.1
70.78
110.86
u/l
3.68
46
210
235
3390
0.68
7.71
2.8
3.1
1.11
1.23
%
1.18
230
3378
54
234
2.32
7.70
1.2
1.1
18.69
39.77
u/l
2.62
45
206
1024
8654
1.23
7.62
2.7
3.0
22.95
23.07
%
0.09
880
8126
508
6455
0.76
7.53
3.9
4.3
5.72
5.79
kpa
1.05
495
6308
56
252
2.24
7.34
1.2
1.3
201.59
350.25
ug/l
0.26
26
119
1086
9267
1.22
7.32
2.7
3.0
2.21
2.22
g/l
0.08
937
8634
496
6294
0.77
7.26
4.0
4.4
2.11
1.63
mmol/l
2.92
405
5479
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
17
38
4.49
7.17
1.1
1.2
2491.50
3524.63
ng/l
—
10
27
32
113
2.84
6.93
2.8
2.4
9.45
7.75
mmol/l
0.41
22
71
105
604
1.75
6.85
1.2
1.5
—
—
—
0
0
106
616
1.74
6.69
1.2
1.5
—
—
—
0
0
0
169
0.00
6.63
0.0
6.9
—
10.37
—
0
169
1131
9772
1.20
6.62
2.7
3.0
12.34
12.71
umol/l
0.89
982
9171
18
45
4.01
6.61
1.1
1.1
—
—
—
0
0
501
3963
1.29
6.55
2.4
2.6
321.15
379.09
nmol/l
10.35
473
3702
2702
25086
1.16
6.55
6.8
8.8
1.21
1.20
mmol/l
14.86
1855
21896
103
600
1.73
6.46
1.2
1.5
—
—
—
0
0
735
6105
1.24
6.37
3.3
2.6
67.79
67.97
e9/l
0.05
629
4600
41
899
0.45
6.31
1.5
1.5
46880.93
57061.34
e6/l
0.23
29
521
21
62
3.40
6.13
1.0
1.1
19.75
21.04
iu/ml
—
8
26
1980
18039
1.16
5.99
2.2
2.3
78.55
76.21
nmol/l
2.96
1667
16034
334
4350
0.75
5.90
2.6
2.9
52.08
63.53
ml/min/173m2
5.53
175
1850
223
1585
1.43
5.87
1.6
1.7
—
—
—
0
0
162
1087
1.51
5.74
1.2
1.2
233.75
271.74
titre
0.08
16
69
23
607
0.38
5.60
1.2
1.3
12.36
4.40
u/ml
0.42
11
308
51
248
2.07
5.59
1.4
1.4
1.34
2.12
u/ml
0.46
21
157
170
2435
0.69
5.43
2.0
2.4
303.08
684.92
ug/l
2.99
163
2335
176
2497
0.69
5.34
2.1
2.6
2.55
2.88
g/l
5.09
158
2282
6
269
0.22
5.33
1.2
2.2
782.17
3538.30
e6/l
—
6
191
10
11
9.11
5.28
1.0
1.0
—
—
—
0
0
97
590
1.66
5.26
1.2
1.5
—
—
—
0
0
96
587
1.65
5.11
1.2
1.5
—
—
—
0
0
8
300
0.27
5.04
1.1
1.4
—
—
—
0
0
8
300
0.27
5.04
1.1
1.4
—
—
—
0
0
6
261
0.23
5.04
2.8
2.2
91.50
92.62
%
—
6
255
96
590
1.64
5.02
1.2
1.5
—
—
—
0
0
164
2314
0.70
4.85
2.5
2.7
2.25
1.00
g/l
1.26
103
2002
30
653
0.46
4.63
3.3
3.6
—
—
—
0
0
29
639
0.45
4.63
1.3
1.5
—
—
—
0
0
13
405
0.32
4.54
1.3
1.2
—
114.62
—
0
13
12
23
5.23
4.45
1.1
1.3
1.00
0.94
u/field
—
7
16
399
3224
1.26
4.44
4.9
4.5
41.48
47.53
%
5.15
390
3179
1500
13633
1.14
4.37
2.4
2.4
3.23
2.85
mg/l
8.87
1239
11785
129
881
1.48
4.29
1.1
1.1
—
—
—
0
0
2353
22047
1.12
4.15
5.7
6.7
59.65
58.92
%
2.28
2261
21022
51
278
1.84
4.13
1.5
1.5
72.14
66.64
%
0.63
43
231
9
283
0.32
4.06
2.2
2.0
—
—
—
0
0
1655
15214
1.13
3.96
1.8
1.8
18.02
18.95
nmol/l
1.58
1213
13046
5
208
0.24
3.95
2.0
2.6
10.20
10.20
kpa
—
5
208
5
208
0.24
3.95
2.0
2.6
4.41
4.88
kpa
—
5
208
6
225
0.27
3.89
1.2
2.1
60610.00
6464.69
e6/l
—
6
126
0
99
0.00
3.84
0.0
1.3
—
—
—
0
0
295
2345
1.27
3.80
3.1
3.6
52.37
55.22
mg/l
0.10
178
2007
27
120
2.26
3.79
1.3
1.3
1.16
1.17
mmol/l
0.70
27
120
295
2347
1.27
3.78
3.1
3.6
46.02
62.46
mg/l
3.40
175
2009
7
8
8.76
3.77
2.0
1.0
—
—
—
0
0
277
3478
0.78
3.76
3.7
5.1
107.22
109.99
ng/l
0.12
189
3060
31
615
0.50
3.75
1.3
1.3
1.40
4.58
u/ml
2.18
15
226
445
5307
0.82
3.75
3.5
3.5
4.44
4.52
kpa
0.49
431
5171
104
701
1.49
3.74
4.1
3.7
55.85
58.86
%
0.68
91
595
17
61
2.79
3.68
1.2
1.2
—
—
—
0
0
542
6311
0.84
3.51
7.9
8.2
11.09
11.13
mmol/l
0.05
512
6044
2121
22553
0.90
3.48
1.9
2.3
92.41
91.46
pmol/l
0.44
1214
13323
137
992
1.39
3.40
1.4
1.3
—
—
—
0
0
44
245
1.80
3.39
1.8
2.0
41.74
39.80
g/l
1.03
44
245
68
427
1.60
3.39
1.1
1.1
2.79
2.07
iu/ml
—
5
15
8
240
0.33
3.28
4.3
2.6
0.60
0.61
mmol/l
—
8
240
350
2895
1.22
3.22
2.4
2.1
1.09
1.36
g/l
1.49
326
2638
478
4074
1.19
3.21
4.6
9.4
24.33
24.55
mmol/l
0.77
468
4042
487
4161
1.19
3.18
2.6
2.4
146.69
175.77
ug/g
1.55
340
3370
832
7413
1.15
3.17
1.3
1.2
2.10
2.26
u/ml
0.13
311
1856
210
2665
0.78
3.15
2.0
2.5
3.92
3.75
g/l
0.39
193
2448
91
1310
0.69
3.13
1.4
1.6
—
—
—
0
0
38
208
1.83
3.12
1.8
2.7
—
—
—
0
0
38
208
1.83
3.12
1.8
2.7
—
—
—
0
0
33
174
1.90
3.04
1.3
1.3
37.81
40.58
g/l
0.41
18
94
193
1504
1.29
2.98
1.4
1.6
—
—
—
0
0
2221
20998
1.10
2.96
2.1
2.3
—
—
—
0
0
22
446
0.49
2.92
1.1
1.2
99.35
95.13
%
0.28
17
419
433
3695
1.19
2.89
3.2
2.8
10.51
10.81
g/l
0.70
382
3424
1156
12598
0.89
2.86
2.5
2.8
—
—
—
0
0
92
642
1.44
2.86
2.0
2.3
22.76
25.73
mg/l
0.24
34
233
657
5800
1.15
2.86
1.3
1.3
9.63
13.88
u/ml
1.01
299
2042
273
2233
1.24
2.83
1.4
1.3
309.13
367.54
u/ml
0.32
261
2061
215
2672
0.80
2.74
2.0
2.5
4.24
4.11
g/l
2.02
198
2459
853
7688
1.13
2.72
3.9
4.8
241.92
243.69
u/l
0.13
796
7315
42
248
1.70
2.71
1.2
1.6
8.00
7.42
u/l
0.14
23
197
105
1432
0.73
2.68
1.4
1.5
17372.43
16262.32
e6/l
0.08
92
1010
216
2672
0.80
2.65
2.0
2.5
7.29
7.26
g/l
0.11
198
2453
10
264
0.38
2.62
1.2
1.2
—
—
—
0
0
18
375
0.48
2.62
1.3
1.3
—
250.94
—
0
32
202
2512
0.80
2.61
2.8
2.7
—
—
—
0
0
155
1198
1.30
2.59
1.4
1.4
8.65
6.90
u/l
0.80
115
958
266
3210
0.82
2.59
1.5
1.7
1.60
1.54
g/l
0.48
219
2767
258
2120
1.23
2.59
3.1
3.5
1.61
4.88
ratio
1.36
117
1229
5
166
0.30
2.53
3.2
2.1
44.60
32.30
%
—
5
155
13
50
2.60
2.53
1.0
1.1
—
—
—
0
0
235
1921
1.23
2.49
2.5
1.8
211.18
201.13
pmol/l
0.83
225
1792
36
210
1.72
2.46
1.8
2.7
—
—
—
0
0
184
1466
1.26
2.44
1.3
1.5
—
—
—
0
0
138
1063
1.31
2.39
2.9
3.6
28.74
33.07
mg/l
0.80
102
742
11
265
0.41
2.36
1.2
1.2
—
—
—
0
0
1458
15562
0.91
2.34
2.9
3.6
33.19
38.35
u/l
2.43
1314
14647
456
5204
0.86
2.33
1.7
1.9
1.67
1.64
%
0.18
370
4381
13
291
0.45
2.33
1.2
1.2
—
—
—
0
0
59
865
0.68
2.33
1.2
1.2
1.40
1.43
g/l
0.35
59
865
115
867
1.33
2.33
1.2
1.3
—
—
—
0
0
12
276
0.43
2.31
1.2
1.2
—
—
—
0
0
12
276
0.43
2.31
1.2
1.2
—
—
—
0
0
13
53
2.46
2.27
4.2
2.1
0.60
0.65
ug/l
0.24
13
53
73
513
1.43
2.26
1.5
1.9
—
—
—
0
0
73
513
1.43
2.26
1.5
1.9
—
—
—
0
0
73
513
1.43
2.26
1.5
1.9
—
—
—
0
0
14
60
2.34
2.21
1.1
1.0
—
—
—
0
0
5
9
5.56
2.21
2.2
1.4
—
—
—
0
0
82
1121
0.73
2.19
1.5
1.6
—
—
—
0
0
80
578
1.39
2.14
1.5
1.3
0.22
0.25
nmol/l
—
10
54
6
168
0.36
2.12
1.0
1.1
—
—
—
0
0
19
358
0.53
2.10
1.3
1.3
—
75.67
—
0
30
12
49
2.45
2.10
1.1
1.1
—
—
—
0
0
19
95
2.00
2.10
1.3
1.1
—
—
—
0
0
51
751
0.68
2.09
1.2
1.1
3.07
10.58
eliau/ml
1.64
12
64
75
539
1.40
2.08
1.4
1.3
278.32
280.54
mosm/kgh2o
0.30
66
414
72
514
1.41
2.07
1.5
1.4
144.11
184.96
pmol/l
1.11
72
514
47
309
1.53
2.05
1.7
1.8
249.63
344.21
mu/l
1.89
32
235
73
1003
0.72
2.04
5.5
6.6
12.63
11.73
mg/l
0.87
65
921
62
875
0.71
2.03
1.6
1.5
145.55
158.58
au/ml
0.31
11
270
7
176
0.40
2.02
15.4
14.6
747.29
826.00
nmol/l
—
7
163
1740
16485
1.08
2.02
2.4
2.4
191.45
254.35
u/l
3.89
1573
15634
55
376
1.47
2.00
1.2
1.2
—
86.71
—
0
7
597
5371
1.13
1.99
2.7
2.8
66.25
65.95
g/l
0.45
545
4944
12
257
0.47
1.96
2.9
7.5
23.45
25.17
mmol/l
0.86
12
228
21
112
1.88
1.95
1.2
1.1
—
—
—
0
0
8
185
0.43
1.92
18.9
19.6
1380.63
1296.74
nmol/l
—
8
178
2055
19628
1.08
1.92
5.1
4.5
7.37
9.59
mg/mmol
1.66
1204
13485
1006
9332
1.10
1.89
2.2
1.8
1283.77
1123.59
nmol/l
5.88
670
7155
0
52
0.00
1.88
0.0
1.0
—
—
—
0
0
21
114
1.85
1.86
1.7
1.5
5.83
9.94
%
0.78
12
62
13
59
2.21
1.84
1.2
1.2
—
—
—
0
0
123
1543
0.79
1.81
2.4
2.7
30.94
34.44
umol/l
1.36
113
1369
17
313
0.54
1.79
1.2
1.2
—
—
—
0
0
56
783
0.71
1.78
1.2
1.2
0.79
0.63
ratio
—
8
154
119
942
1.27
1.76
1.2
1.2
3.97
4.51
u/ml
0.18
19
123
118
939
1.26
1.68
1.2
1.2
1.43
3.22
u/ml
—
9
82
62
451
1.38
1.66
1.4
1.3
—
—
—
0
0
139
1130
1.24
1.65
1.8
1.5
0.89
0.87
nmol/l
0.16
121
946
85
650
1.31
1.65
1.4
1.3
236.96
281.60
pmol/l
1.06
71
529
273
2371
1.16
1.59
2.2
1.8
41.47
44.21
nmol/l
1.09
251
2279
188
1583
1.19
1.58
1.4
1.4
—
—
—
0
0
32
207
1.55
1.56
1.2
1.1
1373.91
388.50
ng/l
0.31
11
56
19
107
1.78
1.54
1.2
1.1
—
—
—
0
0
0
42
0.00
1.52
0.0
1.0
—
—
—
0
0
639
5865
1.10
1.52
4.4
4.7
9.20
27.27
ug/l
4.46
523
5011
0
43
0.00
1.52
0.0
1.0
—
—
—
0
0
679
6257
1.10
1.49
1.3
1.3
40.48
41.08
iu/ml
0.03
188
1744
42
292
1.44
1.47
1.8
2.4
126.35
136.88
ng/l
0.12
42
292
68
514
1.33
1.46
2.0
2.1
400.00
1483.08
titre
—
7
26
8
167
0.48
1.46
1.4
1.3
—
—
—
0
0
16
279
0.57
1.44
1.3
1.2
—
—
—
0
0
9
39
2.31
1.43
2.3
1.2
—
—
—
0
0
53
388
1.37
1.41
1.8
2.0
8.57
7.98
mmol/l
0.56
53
388
7
29
2.42
1.39
1.4
1.0
—
—
—
0
0
16
89
1.80
1.37
1.9
2.1
—
—
—
0
0
102
822
1.25
1.36
1.1
1.1
2.27
2.68
—
7
69
262
2299
1.15
1.36
3.3
4.0
24.67
24.66
mmol/l
0.02
229
2106
15
82
1.83
1.35
1.1
1.3
—
—
—
0
0
0
37
0.00
1.34
0.0
1.0
—
—
—
0
0
109
1331
0.82
1.33
1.6
1.6
19.61
24.77
u/ml
0.47
30
273
33
224
1.48
1.33
1.2
1.3
—
—
—
0
0
175
1494
1.18
1.31
1.4
1.5
319.28
244.43
ug/g
3.69
103
955
61
463
1.32
1.31
1.1
1.2
85.75
70.39
u/l
0.44
51
394
42
300
1.40
1.31
1.5
2.1
17.90
15.36
nmol/l
0.95
37
278
349
3884
0.89
1.30
1.5
1.7
—
—
—
0
0
39
544
0.71
1.30
1.1
1.2
104.47
108.63
%
0.47
32
496
3488
34184
1.06
1.29
22.9
25.4
13.77
13.86
%
3.65
3435
33754
29
194
1.50
1.26
1.6
1.8
0.80
2677.91
u/l
—
6
35
23
146
1.58
1.25
2.1
3.2
1.74
1.87
ratio
0.18
23
129
14
77
1.82
1.25
1.2
1.2
6.67
9.33
mg/l
0.56
14
69
103
841
1.23
1.25
1.2
1.2
1.39
5.07
u/ml
—
8
54
186
1608
1.16
1.21
3.1
2.3
102.52
134.80
ug/min
0.43
109
967
33
229
1.44
1.21
1.2
1.2
—
—
—
0
0
169
1450
1.17
1.21
1.6
1.5
—
—
—
0
0
19
116
1.64
1.21
1.2
1.1
—
—
—
0
0
106
1280
0.82
1.19
1.2
1.2
66.67
150.88
titre
2.08
15
114
53
691
0.76
1.16
5.8
4.6
351.84
340.15
umol/l
0.25
38
593
5
20
2.50
1.15
11.8
8.3
—
—
—
0
0
20
126
1.59
1.14
1.2
1.1
—
—
—
0
0
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
756
7093
1.08
1.12
1.8
1.6
2.71
2.91
g/l
1.50
565
4352
35
482
0.72
1.11
1.0
1.0
42.04
40.17
ng/l
0.08
29
337
35
482
0.72
1.11
1.0
1.0
744.45
723.08
ng/l
0.09
29
333
35
482
0.72
1.11
1.0
1.0
479.59
310.80
ng/l
0.49
29
344
15
88
1.71
1.11
1.9
2.1
—
—
—
0
0
74
592
1.25
1.10
2.2
1.8
4.61
4.66
mmol/24h
0.03
62
525
7
138
0.51
1.09
1.1
1.1
—
—
—
0
0
300
2701
1.12
1.09
2.6
2.4
14.61
19.43
au/ml
0.59
21
208
17
104
1.64
1.09
1.1
1.3
—
—
—
0
0
99
820
1.21
1.08
2.1
1.8
259.57
274.18
mu/l
0.22
90
775
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
29
202
1.44
1.07
1.6
1.4
—
1104938.78
iu/ml
—
0
9
225
1995
1.13
1.06
1.7
1.7
37.35
38.20
u/l
0.24
200
1697
32
229
1.40
1.03
1.2
1.1
—
—
—
0
0
9
47
1.92
1.02
1.4
1.4
—
—
—
0
0
28
196
1.43
1.02
1.4
1.5
0.11
0.14
nmol/l
1.24
18
143
36
264
1.37
1.01
1.4
5.3
6150.14
924.39
mg/l
0.39
21
202
12
68
1.77
1.00
1.0
1.1
—
—
—
0
0
418
3850
1.09
0.99
1.2
1.3
—
—
—
0
0
16
100
1.60
0.96
1.1
1.2
—
—
—
0
0
0
31
0.00
0.96
0.0
1.5
—
40.38
—
0
13
149
1709
0.87
0.95
1.3
1.3
—
—
—
0
0
82
987
0.83
0.94
1.7
1.5
—
18.28
—
0
24
6
27
2.22
0.93
1.3
1.3
1.55
1.26
%
—
6
27
26
184
1.42
0.91
1.3
1.3
19.29
12.84
u/l
0.39
19
148
107
912
1.18
0.89
1.3
1.4
6.80
10.30
u/ml
—
5
20
30
219
1.37
0.89
1.2
1.5
—
—
—
0
0
82
979
0.83
0.88
2.7
2.8
1880.13
9248.49
u/ml
—
8
75
19
276
0.69
0.86
1.7
2.1
—
—
—
0
0
186
2084
0.89
0.86
1.9
1.7
0.30
0.33
mg/l
0.38
94
1080
140
1225
1.15
0.85
1.7
1.3
51.15
38.51
u/l
0.20
121
1058
83
697
1.19
0.84
1.2
1.3
—
—
—
0
0
32
422
0.76
0.82
1.5
1.6
—
28.77
—
0
83
271
2473
1.10
0.82
1.4
1.3
66.91
58.79
au/ml
0.26
20
174
2493
24402
1.04
0.79
5.7
6.5
1.67
1.87
e9/l
11.73
2281
21197
2518
24652
1.04
0.79
5.6
6.7
0.19
0.21
e9/l
4.91
2257
21259
42
530
0.79
0.78
1.2
1.2
135.00
154.68
miu/ml
0.15
13
122
12
187
0.64
0.78
1.1
1.6
2.23
8.96
nmol/l
1.49
12
167
0
27
0.00
0.77
0.0
8.9
—
—
—
0
0
71
594
1.20
0.76
1.7
2.0
—
—
—
0
0
9
53
1.70
0.75
1.1
1.1
—
—
—
0
0
45
360
1.25
0.74
1.8
2.0
—
—
—
0
0
68
569
1.20
0.74
1.7
2.0
—
—
—
0
0
26
344
0.75
0.71
1.2
1.1
4.69
3.15
eliau/ml
0.39
18
121
45
555
0.81
0.71
1.2
1.1
—
—
—
0
0
30
388
0.77
0.70
1.0
1.1
—
—
—
0
0
16
110
1.46
0.68
1.0
1.9
1.66
3.51
pmol/l
—
5
39
26
341
0.76
0.68
1.5
1.3
1.13
1.14
nmol/l
0.02
16
251
321
2985
1.08
0.67
3.2
5.7
1.43
1.63
%
2.77
316
2815
25
326
0.77
0.63
1.6
2.0
—
—
—
0
0
17
235
0.72
0.63
6.7
6.5
14.63
73.41
u/ml
—
8
74
1001
9656
1.05
0.63
1.6
1.8
1.28
1.56
mg/l
2.27
782
7717
90
1029
0.87
0.62
1.4
1.4
2122.28
1019.79
e6/l
0.35
82
811
171
1555
1.10
0.61
1.6
1.5
—
—
—
0
0
2685
26415
1.03
0.60
8.6
10.1
4.42
4.46
e9/l
0.29
2491
22692
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
43
354
1.22
0.58
2.0
2.0
19.21
16.47
%
0.81
43
344
0
23
0.00
0.58
0.0
2.3
—
24.25
—
0
13
1963
19223
1.03
0.57
3.6
3.7
55.98
57.66
mg/l
0.05
1180
13708
60
700
0.86
0.56
1.2
1.1
—
22.72
u/ml
—
0
5
52
613
0.85
0.55
2.9
3.1
—
—
—
0
0
15
206
0.73
0.55
1.2
1.2
—
—
—
0
0
34
275
1.24
0.55
1.1
1.1
398.19
354.26
mg/l
0.33
27
247
14
99
1.42
0.54
1.2
1.1
—
—
—
0
0
34
276
1.23
0.53
1.5
1.5
—
—
—
0
0
34
276
1.23
0.53
1.5
1.5
—
—
—
0
0
148
1349
1.10
0.53
1.2
1.4
—
—
—
0
0
112
1245
0.90
0.52
4.2
6.3
985.08
2444.41
iu/ml
0.50
13
214
90
1012
0.89
0.51
1.2
1.3
24.62
22.90
e6/l
0.04
63
745
379
4000
0.94
0.51
3.4
3.8
131.06
129.14
g/l
0.99
361
3891
86
764
1.13
0.49
1.1
1.1
26.77
276.28
iu/ml
0.59
24
146
109
1206
0.90
0.48
2.9
3.0
0.86
0.81
nmol/l
0.58
77
945
7
46
1.52
0.48
1.4
1.0
—
—
—
0
0
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
13
94
1.38
0.46
1.1
1.3
382.89
971.38
ng/l
—
6
70
17
129
1.32
0.45
1.2
1.2
10.12
12.33
mm/h
0.40
17
129
79
703
1.13
0.45
1.1
1.1
—
—
—
0
0
757
7820
0.96
0.44
6.1
7.4
1.01
1.03
mmol/l
1.13
699
7400
7
51
1.37
0.44
2.6
4.1
—
—
—
0
0
35
415
0.84
0.43
1.3
1.2
—
—
—
0
0
49
424
1.16
0.42
1.1
1.1
1.48
1.72
—
5
44
227
2413
0.94
0.41
1.9
1.6
16.51
19.48
iu/ml
—
10
58
0
15
0.00
0.41
0.0
1.1
—
0.35
—
0
9
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
12
161
0.74
0.41
1.1
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.6
—
1.32
—
0
10
0
17
0.00
0.40
0.0
1.6
—
3.68
—
0
10
0
17
0.00
0.40
0.0
1.6
—
0.25
—
0
10
0
17
0.00
0.40
0.0
1.6
—
2.20
—
0
11
0
17
0.00
0.40
0.0
1.6
—
0.44
—
0
11
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.6
—
3.33
—
0
11
0
17
0.00
0.40
0.0
1.6
—
1.58
—
0
10
0
17
0.00
0.40
0.0
1.6
—
1.90
—
0
11
0
17
0.00
0.40
0.0
1.6
—
1.77
—
0
9
0
17
0.00
0.40
0.0
1.6
—
2.11
—
0
11
17
132
1.29
0.40
1.5
1.7
2.49
1.86
umol/l
1.64
17
121
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
1167
11936
0.97
0.39
3.5
2.9
0.04
0.09
1.07
82
306
20
161
1.24
0.37
1.1
1.1
—
—
—
0
0
911
9339
0.97
0.36
2.9
3.5
2.46
2.45
mmol/l
1.05
855
8371
23
277
0.83
0.35
1.1
1.2
106.26
92.68
pmol/l
0.78
23
277
24
199
1.21
0.35
1.2
1.3
176.63
194.42
mmol/24h
0.62
24
199
22
181
1.22
0.34
1.0
1.1
1264.36
1495.95
miu/ml
0.57
22
181
128
1375
0.93
0.34
1.0
1.1
—
—
—
0
0
17
137
1.24
0.32
1.1
1.3
14.41
14.02
pmol/l
—
7
58
13
101
1.29
0.31
1.1
1.2
—
—
—
0
0
14
110
1.27
0.31
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
211
1.19
0.31
1.2
1.1
—
—
—
0
0
27
230
1.17
0.31
1.3
1.3
—
—
—
0
0
7
97
0.72
0.30
1.0
1.1
—
—
—
0
0
42
371
1.13
0.30
1.3
1.2
—
—
—
0
0
100
1075
0.93
0.29
1.3
1.8
3.31
5.62
mg/l
2.21
72
800
13
162
0.80
0.28
1.1
1.2
1.22
1.45
mmol/l
—
6
111
123
1154
1.07
0.28
1.2
1.3
670.20
585.85
mg/l
0.45
117
1097
33
289
1.14
0.28
1.1
1.1
60.57
51.20
mg/l
0.33
23
247
142
1340
1.06
0.27
1.8
1.5
0.91
7.91
iu/ml
0.82
23
281
8
65
1.23
0.27
1.4
1.1
—
—
—
0
0
28
244
1.15
0.25
1.0
1.1
—
—
—
0
0
43
477
0.90
0.25
1.1
1.2
—
—
—
0
0
283
2728
1.04
0.25
3.2
6.0
0.76
0.86
%
6.72
277
2564
17
202
0.84
0.24
1.5
1.2
0.55
0.54
ratio
—
7
120
53
484
1.10
0.24
1.2
1.3
1.45
1.27
promille
0.40
41
385
15
124
1.21
0.24
1.4
1.7
—
—
—
0
0
33
370
0.89
0.23
1.1
1.2
8.38
10.05
mmol/l
2.03
33
336
17
143
1.19
0.23
1.1
1.2
—
—
—
0
0
78
727
1.07
0.23
1.1
1.1
1.60
1.55
g/l
0.43
69
666
196
1881
1.04
0.22
3.1
3.4
1114.80
398.11
mg/l
0.38
85
1000
14
116
1.21
0.22
1.1
1.3
—
—
—
0
0
523
5353
0.97
0.22
2.2
2.4
0.20
0.20
g/l
0.27
477
4978
13
156
0.83
0.21
1.0
1.1
38.88
27.45
u/ml
—
6
60
5
43
1.16
0.21
5.8
5.1
—
—
—
0
0
133
1269
1.05
0.20
1.7
1.8
9.46
12.35
mg/l
3.02
127
1185
108
1025
1.05
0.19
1.2
1.2
—
17.70
—
0
7
58
541
1.07
0.18
1.4
1.3
171936.05
167667.55
e6/l
0.01
38
366
7
60
1.17
0.17
1.0
1.0
—
—
—
0
0
25
278
0.90
0.17
2.6
3.5
0.82
1.19
%
0.57
25
278
1965
19500
1.01
0.16
3.7
3.7
8.46
8.36
mmol/l
0.41
1397
16421
28
308
0.91
0.16
1.0
1.1
2.46
1.95
u/ml
—
10
160
44
473
0.93
0.15
1.1
1.1
3.96
1.76
u/ml
0.58
14
262
6
80
0.75
0.15
1.3
3.1
71.08
90.89
pmol/l
—
6
75
14
161
0.87
0.15
1.8
2.0
5658.39
379.62
ug/l
0.43
14
151
32
348
0.92
0.15
1.0
1.1
1.04
1.01
u/ml
0.01
11
179
26
236
1.10
0.14
34.2
29.6
102.38
115.67
ug/l
0.76
21
193
30
275
1.09
0.14
2.1
2.3
—
—
—
0
0
182
1772
1.03
0.12
3.4
3.7
4.38
4.37
pmol/l
0.03
163
1594
1483
14929
0.99
0.11
2.8
3.3
368.47
373.54
umol/l
1.13
1195
13115
154
1504
1.02
0.09
1.6
1.5
5.95
6.47
iu/ml
0.14
36
356
79
817
0.97
0.09
1.5
1.3
264.95
289.38
u/ml
0.27
39
513
298
3025
0.98
0.08
1.4
1.5
—
—
—
0
0
45
471
0.96
0.08
1.3
1.4
—
—
—
0
0
45
471
0.96
0.08
1.1
1.2
7.57
7.85
mmol/l
0.28
38
401
10
113
0.88
0.08
1.3
1.3
129.80
401.04
nmol/24h
—
10
113
7
66
1.06
0.08
1.9
2.5
—
154.01
—
0
14
7
67
1.04
0.08
11.0
10.1
0.34
0.35
umol/l
—
7
61
6
73
0.82
0.07
1.0
1.1
—
—
—
0
0
105
1025
1.02
0.07
1.2
1.2
3.90
3.96
mmol/l
0.20
100
969
11
122
0.90
0.07
1.5
1.4
9.28
9.60
ug/l
0.07
11
122
46
478
0.96
0.06
1.3
1.3
—
—
—
0
0
200
1972
1.01
0.06
1.8
1.9
3.59
3.30
mmol/l
2.52
146
1472
39
375
1.04
0.05
1.4
1.5
—
—
—
0
0
19
178
1.07
0.05
1.4
1.5
30.11
27.02
umol/l
0.93
19
167
36
373
0.96
0.04
1.1
1.1
—
—
—
0
0
83
814
1.02
0.04
1.5
1.3
262.82
482.32
u/l
1.71
74
775
948
9514
1.00
0.04
3.3
3.8
0.82
0.81
mmol/l
0.76
875
9011
46
448
1.03
0.03
1.0
1.1
21.84
17.50
au/ml
0.12
11
81
14
149
0.94
0.03
2.4
2.7
3.93
246.07
ug/l
0.68
14
149
38
369
1.03
0.03
1.4
1.5
—
—
—
0
0
2276
22725
1.00
0.03
4.4
6.1
34.42
34.71
g/l
1.45
2058
21395
151
1495
1.01
0.03
1.2
1.1
71.23
103.85
u/ml
1.19
49
441
14
132
1.06
0.02
1.4
1.3
—
—
—
0
0
992
9900
1.00
0.02
1.9
2.1
—
—
—
0
0
88
889
0.99
0.01
1.4
1.2
—
109.40
—
0
6
17
177
0.96
0.01
1.1
1.1
0.98
1.09
u/l
—
5
78
28
286
0.98
0.00
1.0
1.1
3.63
3.05
u/ml
—
10
127
73
736
0.99
0.00
1.5
1.7
4.24
3.45
iu/l
0.26
27
242
32
318
1.01
0.00
2.3
2.7
204.84
256.25
e6/l
0.73
32
284
55
545
1.01
0.00
1.5
1.7
—
—
—
0
0
10
96
1.04
0.00
1.1
1.3
—
7723.00
—
0
10
23
227
1.01
0.00
1.6
1.6
37.56
94.64
umol/l
—
9
117
297
2966
1.00
0.00
2.2
2.2
3.81
3.63
ratio
1.69
245
2483
0
8
0.00
0.00
0.0
1.0
—
0.01
—
0
8
7
69
1.01
0.00
1.9
2.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
7
79
0.89
-0.00
1.1
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
76.30
—
0
6
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
1.14
—
0
7
8
86
0.93
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.6
—
2.48
—
0
9
122
1220
1.00
-0.00
1.2
1.4
0.25
0.24
g/l
0.38
117
1161
5
49
1.02
-0.00
1.0
1.1
178.52
84.25
u/ml
—
5
49
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_ABNORMAL_SPERMATOZ – Abnormal spermatozoa
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).